Ian Frazer
Cited by
Cited by
Prophylactic human papillomavirus vaccines
DR Lowy, JT Schiller
The Journal of clinical investigation 116 (5), 1167-1173, 2006
Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles
J Zhou, XY Sun, DJ Stenzel, IH Frazer
Virology 185 (1), 251-257, 1991
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses
M Evander, IH Frazer, E Payne, YM Qi, K Hengst, NA McMillan
Journal of virology 71 (3), 2449-2456, 1997
Prevention of cervical cancer through papillomavirus vaccination
IH Frazer
Nature Reviews Immunology 4 (1), 46-55, 2004
New gene functions in megakaryopoiesis and platelet formation
C Gieger, A Radhakrishnan, A Cvejic, W Tang, E Porcu, G Pistis, ...
Nature 480 (7376), 201-208, 2011
Prophylactic HPV vaccines: underlying mechanisms
M Stanley, DR Lowy, I Frazer
Vaccine 24, S106-S113, 2006
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
P Bhat, G Leggatt, N Waterhouse, IH Frazer
Cell death & disease 8 (6), e2836-e2836, 2017
The projected timeframe until cervical cancer elimination in Australia: a modelling study
MT Hall, KT Simms, JB Lew, MA Smith, JML Brotherton, M Saville, ...
The Lancet Public Health 4 (1), e19-e27, 2019
Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability
J Zhou, WJ Liu, SW Peng, XY Sun, I Frazer
Journal of virology 73 (6), 4972-4982, 1999
Common variants in TMPRSS6 are associated with iron status and erythrocyte volume
B Benyamin, MAR Ferreira, G Willemsen, S Gordon, RPS Middelberg, ...
Nature genetics 41 (11), 1173-1175, 2009
Interaction of human papillomaviruses with the host immune system: a well evolved relationship
IH Frazer
Virology 384 (2), 410-414, 2009
Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men
IH Frazer, RM Crapper, G Medley, TC Brown, IR Mackay
The Lancet 328 (8508), 657-660, 1986
HPV6b virus like particles are potent immunogens without adjuvant in man
LF Zhang, J Zhou, S Chen, LL Cai, QY Bao, FY Zheng, JQ Lu, ...
Vaccine 18 (11-12), 1051-1058, 2000
Genetic and environmental causes of variation in basal levels of blood cells
DM Evans, IH Frazer, NG Martin
Twin Research and Human Genetics 2 (4), 250-257, 1999
Papillomavirus capsid binding and uptake by cells from different tissues and species
M Müller, L Gissmann, RJ Cristiano, XY Sun, IH Frazer, AB Jenson, ...
Journal of virology 69 (2), 948-954, 1995
Cervical cancer control, priorities and new directions
J Monsonego, FX Bosch, P Coursaget, JT Cox, E Franco, I Frazer, ...
International Journal of cancer 108 (3), 329-333, 2004
A" public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human …
RW Tindle, GJ Fernando, JC Sterling, IH Frazer
Proceedings of the National Academy of Sciences 88 (13), 5887-5891, 1991
Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin
X Chen, TW Prow, ML Crichton, DWK Jenkins, MS Roberts, IH Frazer, ...
Journal of controlled release 139 (3), 212-220, 2009
Nanopatch‐targeted skin vaccination against West Nile virus and chikungunya virus in mice
TW Prow, X Chen, NA Prow, GJP Fernando, CSE Tan, AP Raphael, ...
Small 6 (16), 1776-1784, 2010
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia
IH Frazer, M Quinn, JL Nicklin, J Tan, LC Perrin, P Ng, VM O’Connor, ...
Vaccine 23 (2), 172-181, 2004
The system can't perform the operation now. Try again later.
Articles 1–20